This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Roche Molecular Systems, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Kevin Janssen: Innovating at F. Hoffmann-La Roche AG
Introduction
Kevin Janssen is a dedicated inventor currently working at F. Hoffmann-La Roche AG in the United States. Despite having no patents registered under his name, Kevin is renowned for his significant contributions to the field and his collaboration with esteemed colleagues.
Latest Patents
As of now, Kevin Janssen does not hold any patents. However, his role at F. Hoffmann-La Roche AG indicates a strong involvement in the research and development process.
Career Highlights
Throughout his career at F. Hoffmann-La Roche AG, Kevin has been a part of numerous innovative projects within the pharmaceutical industry. His work contributes to advancements that impact healthcare and improve patient outcomes.
Collaborations
Kevin collaborates closely with other talented individuals such as Amar Gupta and Nicolas Newton. This teamwork fosters a collaborative environment that encourages innovation and creativity.
Conclusion
While Kevin Janssen may not hold patents at this moment, his work at F. Hoffmann-La Roche AG and collaborations with skilled colleagues highlight his commitment and potential as an innovator in the industry. His contributions are likely to pave the way for future inventions that will impact the healthcare sector significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile